/Investor DB

Okapi Venture Capital — 2016 Investments

2 investments dated 2016 · listed companies and verified rows first · show all

Focal Therapeuticsfocalrx.com𝕏Mar 2016acquired by Hologic · Oct 2018 · $125M

Focal Rx develops bioabsorbable medical devices, specifically the BioZorb 3D Bioabsorbable Marker, for clinical and surgical applications.

HealthtechMedical DevicesAliso Viejo, US

George D Hermann(Executive Officer)inSteven Gex(Executive Officer, Director)Steven Naber(Executive Officer)Gail S Lebovic(Executive Officer, Director)

BoardRobert Brownell(Director)

Board seatSharon Stevenson· per SEC Form D

Co-investorsEmergent Medical Partners, LLP

Welltokwelltok.comOct 2016 · $33.7M

Welltok is an enterprise SaaS platform that enables health plans, employers, providers, and public entities to deliver personalized health improvement resources and incentivize consumer engagement for better health outcomes.

Digital HealthHealthtechSaaSDenver, US

Bob Fabbio(Executive Officer, Director)James J. Sullivan(Executive Officer)Jeffrey H Margolis(Director)Jeff Cohen(Founder)

BoardMohamad Makhzoumi(Director)Nina Kjellson(Director)

Co-investorsBessemer Venture PartnersEmergence Capital PartnersFlare Capital PartnersFlybridge Capital PartnersMiramar Venture PartnersNew Enterprise Associates (NEA)+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.